Feropime TZ 1.125 gm Injection
Marketer
Suncure Lifescience Pvt Ltd
Salt Composition
Cefepime (1000mg) + Tazobactum (125mg)
Overview Feropime TZ 1.125 gm Injection
The dual-antibiotic injection, Feropime TZ (1.125 gm), combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be solely under medical supervision; adhere strictly to the prescribed schedule, completing the entire course regardless of symptom improvement. Commonly reported side effects include nausea, vomiting, diarrhea, and skin rashes. Localized injection site reactions (redness, swelling, pain) are typically transient. Severe or persistent side effects necessitate immediate medical consultation. Allergic reactions (rash, itching, swelling, respiratory distress) demand urgent medical attention. Prior to commencing treatment, inform your physician of all current medications and pre-existing health conditions. Pregnant or lactating individuals should seek medical advice before use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, refrain from operating vehicles if drowsiness or dizziness occurs.
Primary Ingredients of Feropime TZ 1.125 gm Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Feropime TZ 1.125 gm Injection
Infections caused by bacteria
Major Benefits of Feropime TZ 1.125 gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Feropime TZ 1.125 gm Injection:
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
How to use Feropime TZ 1.125 gm Injection:
Administering this medication will be done by your physician or their associate; self-medication is strictly prohibited.
How Feropime TZ 1.125 gm Injection works:
Feropime TZ 1.125 gm Injection unites cefepime, a bacterial cell wall synthesis inhibitor, with tazobactam, a beta-lactamase inhibitor. Cefepime's antibiotic action targets bacterial cell wall formation, hindering their survival. Tazobactam counteracts bacterial enzymes that degrade cefepime, thus broadening cefepime's effectiveness and overcoming bacterial resistance.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol while receiving Feropime TZ 1.125 gm Injection requires careful consideration. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable medication Feropime TZ 1.125 gm is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, data from human studies remain scarce.
Breast feedingSAFE IF PRESCRIBED
Feropime TZ 1.125 gm Injection poses minimal risk during lactation. Research in humans indicates negligible transfer of the medication into breast milk, presenting no appreciable danger to the infant.
DrivingUNSAFE
Following administration of Feropime TZ 1.125 gm Injection, temporary blurred vision may occur. Refrain from driving until visual acuity returns to normal.
KidneyCAUTION
Patients with kidney impairment should use Feropime TZ 1.125 gm Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Feropime TZ 1.125 gm Injection in patients with hepatic impairment appears to present a low risk. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Feropime TZ 1.125 gm Injection :
Omit a Feropime TZ 1.125 gm Injection dose? Seek medical advice immediately.
Facts to Know About Feropime TZ 1.125 gm Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective Agents |



